{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:34:28Z","timestamp":1768919668825,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002190.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000}}],"reference-count":123,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002190.pub5","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T07:52:49Z","timestamp":1495093969000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vaccines for the common cold"],"prefix":"10.1002","volume":"2017","author":[{"given":"Daniel","family":"Simancas-Racines","sequence":"first","affiliation":[{"name":"Universidad Tecnol\u00f3gica Equinoccial; Cochrane Ecuador, Centro de Investigaci\u00f3n en Salud P\u00fablica y Epidemiolog\u00eda Cl\u00ednica (CISPEC), Facultad de Ciencias de la Salud Eugenio Espejo; Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Instituto Universitario del Hospital Italiano; Argentine Cochrane Centre; Potos\u00ed 4234 Buenos Aires Buenos Aires Buenos Aires Argentina C1199ACL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia V","family":"Guerra","sequence":"additional","affiliation":[{"name":"Universidad Tecnol\u00f3gica Equinoccial; Facultad de Ciencias de la Salud Eugenio Espejo; Avenida Mariana de Jes\u00fas y Occidental Quito Pichincha Ecuador 593"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L","family":"Felix","sequence":"additional","affiliation":[{"name":"Universidad Tecnol\u00f3gica Equinoccial; Department of Neonatology; Av. Mariana de Jes\u00fas y Occidental Quito Pichincha Ecuador 593"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Hidalgo","sequence":"additional","affiliation":[{"name":"Universidad Tecnol\u00f3gica Equinoccial; Facultad de Ciencias de la Salud Eugenio Espejo; Avenida Mariana de Jes\u00fas y Occidental Quito Pichincha Ecuador 593"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Martinez-Zapata","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 167 Pavilion 18 Barcelona Catalunya Spain 08025"},{"name":"Universidad Tecnol\u00f3gica Equinoccial; Cochrane Ecuador. Centro de Investigaci\u00f3n en Salud P\u00fablica y Epidemiolog\u00eda Cl\u00ednica (CISPEC). Facultad de Ciencias de la Salud Eugenio Espejo; Avenida Rep\u00fablica de El Salvador 733 y Portugal Edificio Gabriela 3. Of. 403 Casilla Postal 17-17-525 Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archinte.1970.00310060059005","article-title":"Live and inactivated adenovirus vaccines. Clinical evaluation of efficacy in prevention of acute respiratory disease","volume":"125","author":"Griffin","year":"1970","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/145.3.311","article-title":"Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial","volume":"145","author":"Belshe","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD002190.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/jcm.30.8.2064-2070.1992","article-title":"Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children","volume":"30","author":"Belshe","year":"1992","journal-title":"Journal of Clinical Microbiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/425981","article-title":"Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children","volume":"190","author":"Belshe","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/381184","article-title":"Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old","volume":"189","author":"Belshe","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/jcm.29.6.1175-1182.1991","article-title":"Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees","volume":"29","author":"Clements","year":"1991","journal-title":"Journal of Clinical Microbiology"},{"issue":"19","key":"10.1002\/14651858.CD002190.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5322","key":"10.1002\/14651858.CD002190.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bmj.1.5322.34","article-title":"Some attempts to produce an experimental vaccine with rhinoviruses","volume":"1","author":"Doggett","year":"1963","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/iai.5.3.295-299.1972","article-title":"Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers","volume":"5","author":"Dudding","year":"1972","journal-title":"Infection and Immunity"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0264-410X(96)00030-8","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60","volume":"14","author":"Falsey","year":"1996","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/592168","article-title":"Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines - nonadjuvanted vaccine or vaccine adjuvanted with alum - given concomitantly with influenza vaccine to high-risk elderly individuals","volume":"198","author":"Falsey","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Glenn GM Fries LF Thomas DN Smith G Kpamegan E Lu H A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age Journal of Infectious Diseases 2016 411 22","DOI":"10.1093\/infdis\/jiv406"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/INF.0b013e318199c3b1","article-title":"Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children","volume":"28","author":"Gomez","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"17","key":"10.1002\/14651858.CD002190.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0264-410X(99)00527-7","article-title":"Evaluation of the live attenuated cpts 248\/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults","volume":"18","author":"Gonzalez","year":"2000","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428092","article-title":"A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy","volume":"191","author":"Greenberg","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/132.6.623","article-title":"Human responses to two decavalent rhinovirus vaccines","volume":"132","author":"Hamory","year":"1975","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/171.5.1107","article-title":"A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children","volume":"171","author":"Karron","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/514138","article-title":"Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children","volume":"176","author":"Karron","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.inf.0000066244.31769.83","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants","volume":"22","author":"Karron","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Karron RA Mateo JS Thumar B Schaap-Nutt A Buchholz UJ Schmidt AC Evaluation of a live-attenuated human parainfluenza type 1 vaccine in adults and children Journal of Pediatric Infectious Diseases Society 2015 e143 6","DOI":"10.1093\/jpids\/piu104"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Kumpu M Kekkonen RA Korpela R Tynkkynen S J\u00e4rvenp\u00e4\u00e4 S Kautiainen H Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial Beneficial Microbes 2015 631 9","DOI":"10.3920\/BM2014.0164"},{"issue":"42","key":"10.1002\/14651858.CD002190.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1016\/j.vaccine.2009.07.038","article-title":"A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or = 65 years of age","volume":"27","author":"Langley","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/323150","article-title":"Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants","volume":"184","author":"Lee","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2004.04.005","article-title":"Experimental infection of humans with A2 respiratory syncytial virus","volume":"63","author":"Lee","year":"2004","journal-title":"Antiviral Research"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antiviral Therapy"},{"issue":"23","key":"10.1002\/14651858.CD002190.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.vaccine.2005.12.002","article-title":"Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers","volume":"24","author":"Madhi","year":"2006","journal-title":"Vaccine"},{"issue":"24","key":"10.1002\/14651858.CD002190.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-1702(94)90059-0","article-title":"An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines","volume":"32","author":"Murphy","year":"1994","journal-title":"Virus Research"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","article-title":"Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old","volume":"13","author":"Paradiso","year":"1994","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0264-410X(95)00034-X","article-title":"Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection","volume":"13","author":"Piedra","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/oxfordjournals.aje.a120805","article-title":"Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits","volume":"87","author":"Pierce","year":"1968","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"7021","key":"10.1002\/14651858.CD002190.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(58)90870-5","article-title":"Autogenous vaccine in prophylaxis of the common cold","volume":"1","author":"Ritchie","year":"1958","journal-title":"Lancet"},{"issue":"5-6","key":"10.1002\/14651858.CD002190.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0264-410X(01)00388-7","article-title":"Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines","volume":"20","author":"Simoes","year":"2001","journal-title":"Vaccine"},{"issue":"50","key":"10.1002\/14651858.CD002190.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1016\/j.vaccine.2008.09.018","article-title":"Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults","volume":"26","author":"Tang","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/167.1.191","article-title":"Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old","volume":"167","author":"Tristram","year":"1993","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0264-410X(90)90051-M","article-title":"Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines","volume":"8","author":"Watt","year":"1990","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/infdis\/170.2.425","article-title":"Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine","volume":"170","author":"Welliver","year":"1994","journal-title":"Journal of Infectious Diseases"},{"issue":"5179","key":"10.1002\/14651858.CD002190.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.1.5179.1081","article-title":"Trial of adenovirus vaccine in Royal Air Force recruits","volume":"1","author":"Wilson","year":"1960","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(76)81044-X","article-title":"Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants","volume":"88","author":"Wright","year":"1976","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0046|cit46","article-title":"Glossary","volume-title":"Basic Immunology","volume":"1","author":"Abbas","year":"2001"},{"issue":"200","key":"10.1002\/14651858.CD002190.pub5-BIB0047|cit47","first-page":"1","article-title":"Current estimates from the National Health Interview Survey 1996","volume":"10","author":"Adams","year":"1999","journal-title":"Vital Health Statistics"},{"issue":"7003","key":"10.1002\/14651858.CD002190.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"issue":"15","key":"10.1002\/14651858.CD002190.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Anonymous","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/jcm.35.11.2864-2868.1997","article-title":"Frequency and natural history of rhinovirus infections in adults during autumn","volume":"35","author":"Arruda","year":"1997","journal-title":"Journal of Clinical Microbiology"},{"issue":"7454","key":"10.1002\/14651858.CD002190.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4049\/jimmunol.161.5.2473","article-title":"Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB\/c mice sensitized to the attachment G protein","volume":"161","author":"Bembridge","year":"1998","journal-title":"Journal of Immunology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD002190.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/13.Supplement_6.S454","article-title":"Epidemiology of acute respiratory infections in children of developing countries","volume":"13","author":"Berman","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/522969","article-title":"Emergence of adenovirus type 14 in US military recruits - a new challenge","volume":"196","author":"Binn","year":"2007","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0055|cit55","unstructured":"Division of Disease Control and Prevention Utah Department of Health Difference between cold and flu symptoms health.utah.gov\/epi\/diseases\/flu\/ColdvsFlu.pdf"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.71.6.871","article-title":"Croup: an 11 year study in a pediatric practice","volume":"71","author":"Denny","year":"1983","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.0713622","article-title":"A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen PHl p1","volume":"182","author":"Edlmayr","year":"2009","journal-title":"Journal of Immunology"},{"issue":"2-4","key":"10.1002\/14651858.CD002190.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/17402520600579168","article-title":"Towards a coronavirus-based HIV multigene vaccine","volume":"13","author":"Eriksson","year":"2006","journal-title":"Clinical and Developmental Immunology"},{"issue":"6 pt 1","key":"10.1002\/14651858.CD002190.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1542\/peds.111.6.1407","article-title":"Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children","volume":"111","author":"Esper","year":"2003","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0060|cit60","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-0036-4","volume-title":"Viral Infection of Humans: Epidemiology and Control","author":"Evans","year":"1997"},{"issue":"17","key":"10.1002\/14651858.CD002190.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0062|cit62","unstructured":"Fermi Paradox www.crystalinks.com\/fermiparadox.html"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM197809282991304","article-title":"The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 \"negative\" trials","volume":"299","author":"Freiman","year":"1978","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub5-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMp1207437","article-title":"Getting the methods right - the Foundation of Patient-Centered Outcomes Research","volume":"367","author":"Gabriel","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.283.4.499","article-title":"Impact of respiratory infection on persons with chronic underlying conditions","volume":"283","author":"Glezen","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0066|cit66","article-title":"Overview of the immune system","volume-title":"Kuby Immunology","volume":"3","author":"Goldsby","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/322627","article-title":"Excessive antibiotic use for acute respiratory infections in the United States","volume":"33","author":"Gonzales","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0068|cit68","article-title":"Problem-based immunology","volume-title":"Inmunolog\u00eda Basada en Problemas","volume":"138","author":"Gorczynski","year":"2007"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0069|cit69","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1086\/522188","article-title":"Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006","volume":"45","author":"Gray","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/epirev\/24.1.4","article-title":"Design of randomized trials","volume":"24","author":"Green","year":"2002","journal-title":"Epidemiologic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3038.2007.00688.x","article-title":"History of respiratory infections in the first 12 yr among children from a birth cohort","volume":"9","author":"Gr\u00fcber","year":"2008","journal-title":"Pediatric Allergy and Immunology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jama.1967.03130190100014","article-title":"Rhinovirus infections in an industrial population II. Characteristics of illness and antibody response","volume":"202","author":"Gwaltney","year":"1967","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0074|cit74","first-page":"265","article-title":"Virology and immunology of the common cold","volume":"23","author":"Gwaltney","year":"1985","journal-title":"Rhinology"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0075|cit75","first-page":"651","article-title":"The common cold","volume-title":"Principles and Practices of Infectious Diseases","author":"Gwaltney","year":"2000"},{"issue":"25","key":"10.1002\/14651858.CD002190.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0077|cit77","volume-title":"Harrison Principios de Medicina Interna","author":"Fauci","year":"2008"},{"issue":"9351","key":"10.1002\/14651858.CD002190.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/clinids\/18.5.770","article-title":"Epidemiology and cost of infection with human parainfluenza viruses types 1 and 2 in young children","volume":"18","author":"Henrickson","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0081|cit81","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.4049\/jimmunol.161.11.6215","article-title":"Host genetic determinants of vaccine-induced eosinophilia during RSV infection","volume":"161","author":"Hussell","year":"1998","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD002190.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub5-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006207.pub4","article-title":"Physical interventions to interrupt or reduce the spread of respiratory viruses","author":"Jefferson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD002190.pub5-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004879.pub4","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00001432-200306000-00012","article-title":"Human metapneumovirus: a newly emerging respiratory pathogen","volume":"16","author":"Kahn","year":"2003","journal-title":"Current Opinion in Infection Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10059-009-0015-1","article-title":"Host responses from innate to adaptive immunity after vaccination: molecular and cellular events","volume":"27","author":"Kang","year":"2009","journal-title":"Molecular Cell"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.2002.tb04759.x","article-title":"Determining the sample size in a clinical trial","volume":"177","author":"Kirby","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00006454-198505000-00009","article-title":"Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome","volume":"4","author":"Krasinski","year":"1985","journal-title":"Pediatric Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jmv.1890050306","article-title":"Isolation of rhinoviruses and coronaviruses from 38 colds in adults","volume":"5","author":"Larson","year":"1980","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/JCM.02614-05","article-title":"Coronavirus HKU1 and other coronavirus infection in Hong Kong","volume":"44","author":"Lau","year":"2006","journal-title":"Journal of Clinical Microbiology"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"399-404","DOI":"10.1111\/j.1467-842X.2003.tb00416.x","article-title":"A community-based study of respiratory episodes in Melbourne, Australia","volume":"27","author":"Leder","year":"2003","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2005.06.024","article-title":"Rhinovirus illnesses during infancy predict subsequent childhood wheezing","volume":"116","author":"Lemanske","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9128","key":"10.1002\/14651858.CD002190.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268800050779","article-title":"Acute respiratory illness in the community. Frequency of illness and the agents involved","volume":"110","author":"Monto","year":"1993","journal-title":"Epidemiology and Infection"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.36.2.539-542.1998","article-title":"Viruses and bacteria in the etiology of the common cold","volume":"36","author":"M\u00e4kel\u00e4","year":"1998","journal-title":"Journal of Clinical Microbiology"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0102|cit102","volume-title":"Nelson Tratado de Pediatr\u00eda","author":"Kliegman","year":"2000"},{"issue":"7115","key":"10.1002\/14651858.CD002190.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bmj.315.7115.1060","article-title":"Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective population based study of disease burden","volume":"315","author":"Nicholson","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5694\/j.1326-5377.2002.tb04354.x","article-title":"Evidence of human metapneumovirus in Australian children","volume":"176","author":"Nissen","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"5923","key":"10.1002\/14651858.CD002190.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1165557","article-title":"Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution","volume":"324","author":"Palmemberg","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcv.2008.08.014","article-title":"Clinical effects of rhinovirus infections","volume":"43","author":"Peltola","year":"2008","journal-title":"Journal of Clinical Virology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"21","key":"10.1002\/14651858.CD002190.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMcibr0902053","article-title":"Common cold, uncommon variation","volume":"360","author":"Poland","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1183\/09031936.00076508","article-title":"Rhinovirus infections in infants: is respiratory syncytial virus ready for the challenge?","volume":"32","author":"Regamey","year":"2008","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"41601","DOI":"10.1038\/srep41601","article-title":"Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21","volume":"7","author":"Ren","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0112|cit112","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub5-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/ijms18030556","article-title":"Immunological features of respiratory syncytial virus-caused pneumonia - implications for vaccine design","volume":"18","author":"Rey-Jurado","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0114|cit114","first-page":"2769","article-title":"Human metapneumovirus - occurrence and clinical significance","volume":"20","author":"Risnes","year":"2005","journal-title":"Tidsskrift for den Norske Laegeforening"},{"key":"10.1002\/14651858.CD002190.pub5-BIB0115|cit115","article-title":"Glossary","volume-title":"Essential Immunology","volume":"466","author":"Roitt","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub5-BIB0116|cit116","first-page":"25","article-title":"Colds and influenza: a review of diagnosis and conventional, botanical and nutritional considerations","volume":"12","author":"Roxas","year":"2007","journal-title":"Alternative Medicine Review"},{"issue":"15","key":"10.1002\/14651858.CD002190.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","article-title":"Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004","volume":"24","author":"Russell","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"49","key":"10.1002\/14651858.CD002190.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1016\/j.vaccine.2008.09.080","article-title":"Deceptive imprinting and immune refocusing in vaccine design","volume":"26","author":"Tobin","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2004.01.006","article-title":"The common cold: a review of the literature","volume":"15","author":"Wat","year":"2004","journal-title":"European Journal of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub5-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002190.pub3","article-title":"Vaccines for the common cold","author":"Felix","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub5-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002190.pub4","article-title":"Vaccines for the common cold","author":"Simancas-Racines","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002190.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002190.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:39:06Z","timestamp":1692808746000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002190.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Acute Respiratory Infections Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":123,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002190.pub5","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD002190.pub6","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}